Related Experiment Video
Updated: May 16, 2026
Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Stem cells therapy for cardiovascular repair in ischemic heart disease: How to predict and secure optimal outcome?
1Cardiac Stem Cell laboratory and Cardiac Catheterization Laboratory 2014, The Hearth Centre, Rigshospitalet, Copenhagen University Hospital and Faculty of Health Sciences, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
Insights
Stem cell therapy shows promise for cardiac regeneration in ischemic heart disease. This review examines clinical trials to personalize stem cell treatments for better patient outcomes.
Area of Science:
- Cardiology
- Regenerative Medicine
- Stem Cell Therapy
Background:
- Coronary artery disease (CAD) remains a leading cause of mortality and hospitalization globally.
- While revascularization improves outcomes, significant challenges persist in managing myocardial damage.
- Stem cell therapy offers a novel approach for cardiac regeneration, but clinical results are inconsistent.
Purpose of the Study:
- To review clinical stem cell trials for cardiac regeneration in ischemic heart disease.
- To identify factors influencing treatment efficacy and patient response.
- To guide the prediction and personalization of stem cell therapy for improved outcomes.
Main Methods:
- Systematic review of conducted clinical stem cell trials.
- Analysis of study designs, patient selection criteria, and therapeutic outcomes.
- Exploration of potential biomarkers and predictive factors for treatment success.
Main Results:
- Inconsistent outcomes reported across clinical stem cell trials for cardiac regeneration.
- Variability in results attributed to differences in study protocols and patient cohorts.
- Emerging evidence suggests patient-specific factors influence therapeutic response.
Conclusions:
- Personalization of stem cell therapy is crucial for effective cardiac regeneration.
- Further research is needed to establish predictive models for patient selection.
- Optimizing stem cell treatment strategies can improve management of ischemic heart disease.
Abstract:
Coronary artery disease is a growing problem worldwide. Early treatment with stabilizing drugs and revascularization by percutaneous coronary intervention or by-pass surgery has reduced the mortality significantly, but it is still the most common cause of death and a major cause of hospital admissions in industrialized countries. Treatment with stem cells with the potential to regenerate the damaged myocardium is a relatively new approach. However, the results from clinical studies on stem cell therapy for cardiac regeneration in patients with acute or chronic ischemic heart disease have been inconsistent. Some of the discrepancy could be due differences in study designs or patient selection. The review will based on conducted clinical stem cell trials try to elucidate how to predict and personalize this new treatment approach.
